T6338 |
PHA-680632
|
398493-79-3
|
99.03%
|
|
PHA-680632 is potent inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 27 nM, 135 nM and 120 nM, respectively. It has 10- to 200-fold higher IC50 for FGF...
|
T8541 |
Lenvatinib mesylate
|
857890-39-2
|
99.03%
|
|
Lenvatinib mesylate (E7080 (mesylate)) is an oral and multi-targeted inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, with potent antitumor activities.
|
TQ0256 |
FGFR4-IN-1
|
1708971-72-5
|
98.96%
|
|
FGFR4-IN-1 is a potent FGFR4 inhibitor (IC50: 0.7 nM).
|
T6024 |
Zoligratinib
|
1265229-25-1
|
98.94%
|
|
Zoligratinib (CH5183284) is a selective and orally available FGFR inhibitor, which is for FGFR1(IC50=9.3 nM), FGFR2(IC50=7.6 nM), FGFR3(IC50=290), and FGFR4(IC50...
|
T4075 |
Sulfatinib
|
1308672-74-3
|
98.93%
|
|
Sulfatinib (KDR-IN-1) (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC 50 s ranging from 1 to 24...
|
T5122 |
Alofanib
|
1612888-66-0
|
98.82%
|
|
Alofanib (RPT835) is a selective allosteric inhibitor of FGFR2 and has a dramatic inhibitory effect on FGF2-induced phosphorylation of FRS2a in KATO III cells (I...
|
T7611 |
ODM-203
|
1430723-35-5
|
98.77%
|
|
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity
|
T10870L |
CP-547632
|
252003-65-9
|
98.51%
|
|
CP-547632 is an orally available and potent, ATP-competitive dual inhibitor of VEGFR-2 and FGF kinase F with IC50s of 11 nM and 9 nM, respectively. CP-547632 is ...
|
T1886 |
TAK-632
|
1228591-30-7
|
98.5%
|
|
TAK-632 is a potent pan-Raf inhibitor.
|
T0520 |
Lenvatinib
|
417716-92-8
|
98.46%
|
|
Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, and RET, and has oral activity. Lenvatinib h...
|
T2094 |
Danusertib
|
827318-97-8
|
98.44%
|
|
Danusertib (PHA-739358) is a small-molecule 3-aminopyrazole derivative with potential antineoplastic activity. Danusertib binds to and inhibits the Aurora kinase...
|
T3714 |
SUN11602
|
704869-38-5
|
98.43%
|
|
SUN11602, an aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor. It mimics the neuroprotective effects of bFGF and prevent...
|
T2642 |
PD173074
|
219580-11-7
|
98.15%
|
|
PD173074 is an effective FGFR1 inhibitor (IC50: 25 nM) and also inhibits VEGFR2 (IC50: 100-200 nM) in cell-free assays. The selectivity is higher ~1000-fold for ...
|
T1975 |
Infigratinib
|
872511-34-7
|
98.03%
|
|
Infigratinib (NVP-BGJ398) (BGJ398) is an orally bioavailable pan FGFR inhibitor (IC50: 0.9/1.4/1 nM for FGFR1/2/3), >40-fold selective for FGFR versus FGFR4 and ...
|
T3456 |
Fisogatinib
|
1707289-21-1
|
98%
|
|
Fisogatinib (BLU-554) is a potent inhibitor of fibroblast growth factor receptor 4 (FGFR4).
|
T2358 |
ENMD-2076
|
934353-76-1
|
98%
|
|
ENMD-2076, a multi-targeted kinase inhibitor, has specific activity against Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFRα.
|
T6082 |
SSR128129E
|
848318-25-2
|
98%
|
|
SSR128129E (SSR) is an allosteric and orally-active FGFR1 inhibitor (IC50: 1.9 μM), but not affecting other related RTKs.
|
T3466 |
FIIN-3
|
1637735-84-2
|
97.7%
|
|
FIIN-3 is an irreversible inhibitor of FGFR.
|
T3274 |
S49076
|
1265965-22-7
|
97.4%
|
|
S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3, blocking cellular phosphorylation of MET, AXL, and FGFRs.
|
T37426 |
FIIN-1
|
1256152-35-8
|
97.30%
|
|
FIIN-1 (FGFR irreversible inhibitor-1) is an irreversible and selective FGFR inhibitor with Kd of 2.8, 6.9, 5.4, 120, 32 and 120 nM for FGFR1, FGFR2, FGFR3, FGFR...
|